Contributions of KRAS and RAL in Non-Small Cell Lung Cancer growth and progression

INTRODUCTION: KRAS mutations are poor prognostic markers for patients with non-small cell lung cancer (NSCLC). RALA and RALB GTPases lie downstream of RAS and are implicated in RAS mediated tumorigenesis. However, their biological or prognostic role in the context of KRAS mutation in NSCLC is unclea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Guin, Sunny, Ru, Yuanbin, Wynes, Murry W., Mishra, Rangnath, Lu, Xian, Owens, Charles, Barόn, Anna E., Vasu, Vihas T., Hirsch, Fred R., Kern, Jeffrey A., Theodorescu, Dan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934792/
https://ncbi.nlm.nih.gov/pubmed/24389431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller